Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.91 USD | +1.46% | -0.76% | +45.41% |
05-14 | Kura Oncology Enrolls 85 Patients in Ziftomenib Trial for Leukemia Drug | MT |
05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.41% | 1.57B | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Transcript : Kura Oncology, Inc. - Special Call